Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study-Reference-Cited by-同舟云学术

Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study

Published:2020-05-15 Issue:14 Volume:126 Page:3322-3329
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Arora Mukta¹^ORCID,Chen Yanjun²,Hageman Lindsey²,Wu Jessica²,Landier Wendy²,Francisco Liton²,Kung Michelle²,Ness Emily²,Bosworth Alysia³,Pamukcuoglu Merve¹,Weisdorf Daniel J.¹,Forman Stephen J.³,Armenian Saro H.³^ORCID,Bhatia Smita²^ORCID

Affiliation:

1. Division of Hematology, Oncology and Transplantation University of Minnesota Minneapolis Minnesota USA

2. Institute for Cancer Outcomes and Survivorship University of Alabama at Birmingham Birmingham Alabama USA

3. Department of Population Sciences City of Hope National Medical Center Duarte California USA

Funder

National Cancer Institute

Leukemia and Lymphoma Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32941

Reference36 articles.

1. Recent advances in understanding multiple myeloma

2. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

3. Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

4. Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up

5. Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors—A Literature Review;Journal of Clinical Medicine;2024-08-01

2. Psychoneuroimmunology in multiple myeloma and autologous hematopoietic stem cell transplant: Opportunities for research among patients and caregivers;Brain, Behavior, and Immunity;2024-07

3. Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy;Cancers;2023-12-05

4. Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report;Blood Advances;2023-11-20

5. EXABS-243-CT Late/Deferred ASCT in Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-09